Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19

americanpharmaceuticalreviewJanuary 15, 2021

Tag: DalCor , COVID-19 , dal-COVID , dalcetrapib , 3CLMpro

PharmaSources Customer Service